My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

48.24 -0.61 (-1.24%)
Streaming Delayed Price Updated: 11:21 AM EDT, Sep 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Examining the Future: Harrow's Earnings Outlook
 
Via Benzinga
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
From Harrow, Inc.
Via Business Wire
Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients
From Harrow, Inc.
Via Business Wire
Where Harrow Stands With Analysts
 
Via Benzinga
Wondering what's happening in today's after-hours session?
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results
From Harrow, Inc.
Via Business Wire
Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025
From Harrow, Inc.
Via Business Wire
Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL
From Harrow, Inc.
Via Business Wire
S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge
 
Via Benzinga
Topics Stocks
Traders are paying attention to the gapping stocks in Tuesday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Discover the top movers in Tuesday's pre-market session.
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'
U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading. 
Via Benzinga
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Top movers in Monday's after hours session
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance
From Harrow, Inc.
Via Business Wire
Harrow Launches VEVYE® Access for All
From Harrow, Inc.
Via Business Wire
Earnings Scheduled For March 17, 2025
 
Via Benzinga
Harrow Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
 
Via Benzinga
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
From Harrow, Inc.
Via Business Wire
Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025
From Harrow, Inc.
Via Business Wire
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
 
Via Benzinga
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients
From Harrow, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
From Harrow, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
From Harrow, Inc.
Via Business Wire
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
From Melt Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.